Gigante, M; Blasi, A; Loverre, A et al. (2009) Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine. Mol Immunol 46:893-901
|
Komita, Hideo; Zhao, Xi; Taylor, Jennifer L et al. (2008) CD8+ T-cell responses against hemoglobin-beta prevent solid tumor growth. Cancer Res 68:8076-84
|
Wesa, A K; Storkus, W J (2008) Killer dendritic cells: mechanisms of action and therapeutic implications for cancer. Cell Death Differ 15:51-7
|
Wesa, Amy; Kalinski, Pawel; Kirkwood, John M et al. (2007) Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro. J Immunother 30:75-82
|
Vujanovic, L; Ranieri, E; Gambotto, A et al. (2006) IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. Cancer Gene Ther 13:798-805
|
Herrem, Christopher J; Tatsumi, Tomohide; Olson, Kathleen S et al. (2005) Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma. Clin Cancer Res 11:226-31
|
Muller-Berghaus, Jan; Olson, Walter C; Moulton, Rachel A et al. (2005) IL-12 production by human monocyte-derived dendritic cells: looking at the single cell. J Immunother 28:306-13
|
Warrino, Dominic E; Olson, Walter C; Scarrow, Meera I et al. (2005) Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro. Hum Immunol 66:762-72
|
Rayman, Patricia; Wesa, Amy K; Richmond, Amy L et al. (2004) Effect of renal cell carcinomas on the development of type 1 T-cell responses. Clin Cancer Res 10:6360S-6S
|
Warrino, Dominic E; Olson, Walter C; Knapp, William T et al. (2004) Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes. Clin Cancer Res 10:3301-8
|
Showing the most recent 10 out of 41 publications